Unknown

Dataset Information

0

Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.


ABSTRACT: This work provides a perspective on the qualification and verification of physiologically based pharmacokinetic (PBPK) platforms/models intended for regulatory submission based on the collective experience of the Simcyp Consortium members. Examples of regulatory submission of PBPK analyses across various intended applications are presented and discussed. European Medicines Agency (EMA) and US Food and Drug Administration (FDA) recent draft guidelines regarding PBPK analyses and reporting are encouraging, and to advance the use and acceptability of PBPK analyses, more clarity and flexibility are warranted.

SUBMITTER: Shebley M 

PROVIDER: S-EPMC6032820 | biostudies-other | 2018 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications

Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.

Shebley Mohamad M   Sandhu Punam P   Emami Riedmaier Arian A   Jamei Masoud M   Narayanan Rangaraj R   Patel Aarti A   Peters Sheila Annie SA   Reddy Venkatesh Pilla VP   Zheng Ming M   de Zwart Loeckie L   Beneton Maud M   Bouzom Francois F   Chen Jun J   Chen Yuan Y   Cleary Yumi Y   Collins Christiane C   Dickinson Gemma L GL   Djebli Nassim N   Einolf Heidi J HJ   Gardner Iain I   Huth Felix F   Kazmi Faraz F   Khalil Feras F   Lin Jing J   Odinecs Aleksandrs A   Patel Chirag C   Rong Haojing H   Schuck Edgar E   Sharma Pradeep P   Wu Shu-Pei SP   Xu Yang Y   Yamazaki Shinji S   Yoshida Kenta K   Rowland Malcolm M  

Clinical pharmacology and therapeutics 20180202 1


This work provides a perspective on the qualification and verification of physiologically based pharmacokinetic (PBPK) platforms/models intended for regulatory submission based on the collective experience of the Simcyp Consortium members. Examples of regulatory submission of PBPK analyses across various intended applications are presented and discussed. European Medicines Agency (EMA) and US Food and Drug Administration (FDA) recent draft guidelines regarding PBPK analyses and reporting are enc  ...[more]

Similar Datasets

| S-EPMC4429575 | biostudies-literature
| S-EPMC1090550 | biostudies-literature
| S-EPMC5697013 | biostudies-literature
| S-EPMC5597447 | biostudies-literature
| S-EPMC8359227 | biostudies-literature
| S-EPMC3836053 | biostudies-literature
| S-EPMC4540731 | biostudies-literature
| S-EPMC4752336 | biostudies-literature
| S-EPMC7520419 | biostudies-literature
| S-EPMC1373666 | biostudies-literature